Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 7 studies | 29% ± 8% | |
enterocyte | 4 studies | 40% ± 14% | |
brush cell | 4 studies | 58% ± 16% | |
epithelial cell | 3 studies | 29% ± 9% |
Insufficient scRNA-seq data for expression of ANXA13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 957.17 | 956 / 966 | 82% | 24.37 | 432 / 527 |
liver | 95% | 218.20 | 214 / 226 | 70% | 38.50 | 284 / 406 |
kidney | 85% | 167.25 | 76 / 89 | 71% | 21.53 | 642 / 901 |
stomach | 52% | 45.94 | 187 / 359 | 81% | 19.86 | 232 / 286 |
esophagus | 66% | 77.96 | 950 / 1445 | 35% | 13.29 | 64 / 183 |
uterus | 86% | 126.19 | 146 / 170 | 6% | 0.94 | 29 / 459 |
pancreas | 17% | 11.34 | 55 / 328 | 64% | 19.47 | 114 / 178 |
ovary | 58% | 29.36 | 104 / 180 | 13% | 1.01 | 54 / 430 |
bladder | 38% | 34.43 | 8 / 21 | 22% | 5.95 | 110 / 504 |
breast | 55% | 31.51 | 253 / 459 | 1% | 0.05 | 6 / 1118 |
prostate | 47% | 35.30 | 115 / 245 | 2% | 0.15 | 9 / 502 |
brain | 26% | 47.02 | 686 / 2642 | 1% | 0.05 | 7 / 705 |
lung | 8% | 3.81 | 46 / 578 | 13% | 3.70 | 151 / 1155 |
adipose | 19% | 7.89 | 229 / 1204 | 0% | 0 | 0 / 0 |
skin | 6% | 2.12 | 111 / 1809 | 4% | 0.37 | 20 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.29 | 2 / 45 |
heart | 2% | 0.62 | 14 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.11 | 1 / 258 | 1% | 0.18 | 2 / 230 |
muscle | 1% | 0.31 | 9 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.25 | 14 / 1335 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.08 | 2 / 653 | 1% | 0.03 | 4 / 605 |
spleen | 1% | 0.22 | 2 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.05 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030154 | Biological process | cell differentiation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0012506 | Cellular component | vesicle membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1901611 | Molecular function | phosphatidylglycerol binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
Gene name | ANXA13 |
Protein name | Annexin A13 Annexin Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA) |
Synonyms | ANX13 |
Description | FUNCTION: [Isoform A]: Binds to membranes enriched in phosphatidylserine or phosphatidylglycerol in a calcium-dependent manner . Half-maximal membrane binding requires about 60 uM calcium. Does not bind to membranes that lack phospholipids with an acidic headgroup . .; FUNCTION: [Isoform B]: Binds to membranes enriched in phosphatidylserine or phosphatidylglycerol in a calcium-dependent manner, but requires higher calcium levels for membrane binding than isoform A. Half-maximal membrane binding requires about 320 uM calcium. . |
Accessions | P27216 Q6FHB6 ENST00000262219.10 [P27216-2] E5RIN3 ENST00000419625.6 [P27216-1] ENST00000520519.1 |